ABC's Youri Bendjaoud breaks down a new GLP-1 experimental weight loss drug that could be available as soon as next year.

Lilly said people on the next-generation weight loss medication across three different dosages achieved weight loss of 19% to ...

MEDVi offers GLP-1 weight loss drugs online, but is it worth it? Review pricing, pros, cons, and what customers have to say.

A suite of new studies suggest drugs such as Ozempic and Zepbound might slow tumor progression and improve survival, but more ...

People who got the injection, retatrutide, lost 28 percent of their body weight on average after 80 weeks, Eli Lilly said.

Eli Lilly’s highly anticipated new weight loss drug, retatrutide, helped people lose up to 30% of their body weight, about 85 ...

There's a clear leader, but that may not be the best investment option for you in 2026.

Retatrutide, an experimental injectable drug, targets three hormones related to weight loss.

Mounjaro and Zepbound are two brand-name glucagon-like peptide-1 (GLP-1) medications manufactured by Eli Lilly. Although they ...

Eli Lilly's weight loss drug retatrutide helped nearly half of participants in a phase 3 trial to lose more than 30% of their ...

Remarkable new test results by drugmaker Eli Lilly reveal that their latest weight loss drug, retatrutide, may be even more ...